Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brendan Mcdonnell currently holds 10,000 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brendan Mcdonnell has been a net seller of HEPH stock. They have purchased $57.0K and sold $68.5K worth of shares.
Brendan Mcdonnell's most recent insider trade was on Dec 12, 2006, when they purchased 3,640 shares at $5.50 per share.
Brendan Mcdonnell serves as Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH). They have executed 6 insider transactions totaling $125.5K over their tenure at the company.
Brendan Mcdonnell holds the position of Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Brendan Mcdonnell has shown a selling trading pattern, with $57.0K in total purchases and $68.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brendan Mcdonnell was on Jan 30, 2006, when they sold $37.0K worth of HEPH shares. This transaction involved 5,000 shares at $7.41 per share.
Brendan Mcdonnell currently owns 10,000 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brendan Mcdonnell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brendan Mcdonnell has 6 Form 4 filings on record as an insider at HOLLIS EDEN PHARMACEUTICALS INC /DE/.
Set alerts for Brendan Mcdonnell and 40,000+ other insiders.